バイオテクノロジーニュース
-
October 1 , 2018
Three Emerging Positive Trends to Watch in China Opening Up Huge Long-term Market Opportunity
- Three positive developments in China have evolved recently that could benefit the development, regulatory, reimbursement and - perhaps just as importantly-investment framework for biopharma. While still early, the Chinese govt is shifting from a network mostly "closed" to US Biopharma towards a more "open" and pro-innovation stance for medicine that could th
詳しく見る